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Abstract
Background: SERPINs (serine protease inhibitors) regulate proteases involving fibrinolysis, coagulation,
inflammation, cell mobility, cellular differentiation and apoptosis. This study aimed to investigate differentially
expressed genes of members of the SERPIN superfamily between healthy and atretic follicles using a combination
of microarray and quantitative real-time PCR (QPCR) analysis. In addition, we further determined mRNA and protein
localization of identified SERPINs in estradiol (E2)-active and E2-inactive follicles by in situ hybridization and
immunohistochemistry.
Methods: We performed microarray analysis of healthy (10.7 +/- 0.7 mm) and atretic (7.8 +/- 0.2 mm) follicles
using a custom-made bovine oligonucleotide microarray to screen differentially expressed genes encoding SERPIN
superfamily members between groups. The expression profiles of six identified SERPIN genes were further
confirmed by QPCR analysis. In addition, mRNA and protein localization of four SERPINs was investigated in E2-
active and E2-inactive follicles using in situ hybridization and immunohistochemistry.
Results: We have identified 11 SERPIN genes expressed in healthy and atretic follicles by microarray analysis. QPCR
analysis confirmed that mRNA expression of four SERPINs (SERPINA5, SERPINB6, SERPINE2 and SERPINF2) was greater
in healthy than in atretic follicles, while two SERPINs (SERPINE1 and SERPING1) had greater expression in atretic than
in healthy follicles. In situ hybridization showed that SERPINA5, SERPINB6 and SERPINF2 mRNA were localized in GCs
of E2-active follicles and weakly expressed in GCs of E2-inactive follicles. SERPING1 mRNA was localized in both GCs
and the theca layer (TL) of E2-inactive follicles and a weak hybridization signal was also detected in both GCs and
TL of E2-active follicles. Immunohistochemistry showed that SERPINA5, SERPINB6 and SERPINF2 were detected in
GCs of E2-active and E2-inactive follicles. SERPING1 protein was localized in both GCs and the TL of E2-active and
E2-inactive follicles.
Conclusions: Our results demonstrate a characteristic expression of SERPIN superfamily member genes in bovine
healthy and atretic follicles. The cell-type-and stage-specific expression of SERPINs may be associated with bovine
follicular growth and atresia.
Background
The final growth of bovine antral follicles shows a wave-
like pattern [1,2]. In each follicular wave, usually one
dominant follicle (DF) is selected from a cohort of
growing follicles and continues growth while other folli-
cles undergo atresia [3]. The DF is characterized by
expression of luteinizing hormone (LH) receptor in
granulosa cells (GCs) and enhanced estradiol (E2)p r o -
duction [4]. Various intrafollicular molecules, including
the insulin-like growth factor family and the transform-
ing growth factor-b family, play a crucial role in regulat-
ing DF selection and its further growth [5,6]. In
addition, increasing evidence has revealed that numer-
ous genes are regulated during bovine follicular develop-
ment and ovulation through the use of global
transcription profiling such as microarray analysis
[7-15]. Recently, we investigated differences in global
gene expression profiles between bovine healthy follicles
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microarray [15]. In that study 76 differentially expressed
genes between the follicles were identified, demonstrat-
ing that gene expression in the follicles may be closely
associated with their developmental status (healthy or
atretic). Also in that study, we found several genes cord-
ing for serine protease inhibitors (SERPINs), being
expressed in both healthy and atretic follicles.
SERPINs comprise a huge superfamily of protease
inhibitors with similar structures that undergo confor-
mational changes in the formation of stable complexes
between inhibitor and target enzymes [16]. Most SER-
PINs inactivate serine proteases and some cystein pro-
teases, and they play a functional role in diverse
biological processes including fibrinolysis, coagulation,
inflammation, cell mobility, cellular differentiation and
apoptosis [16,17]. It has been reported that expression
and secretion of three SERPINs, SERPINB2, SERPINE1
and SERPINE2 change in a stage-dependent manner
during bovine follicular development and in the periovu-
latory period [18-21]. The mRNA expression of these
SERPINs in preovulatory follicles was markedly up-regu-
lated immediately after the beginning of the LH surge,
then decreased to a nadir level near the time of ovula-
tion [18,21]. During follicular development, SERPINE2
mRNA levels were higher in GCs of DF compared to
small follicles [19] while the follicular fluid (FF) concen-
tration of SERPINE2 was significantly higher in non-
atretic than in atretic follicles [21]. An in vitro study
demonstrated that cultured GCs from large follicles
secreted more SERPINE2 than GCs from small and
medium-sized follicles [20]. All of these three SERPINs
are involved in the regulation of follicular extracellular
matrix (ECM) remodeling to inhibit activity of plasmi-
nogen activators (PAs) and/or plasmin.
Even though a number of SERPINs with various func-
tions are known, the presence of other SERPINs except
for the above three SERPINs have not been examined in
bovine follicles. We hypothesized that temporal and
cell-specific regulation of SERPIN expression could con-
tribute to follicular development in cattle. The aim of
this study was to identify differentially expressed SER-
PIN genes between healthy and atretic follicles using a
combination of microarray analysis and quantitative
real-time PCR (QPCR) analysis. Moreover, mRNA and
protein localization of several identified SERPINs was
further investigated in E2-active and E2-inactive follicles
using in situ hybridization and immunohistochemistry.
Methods
In the present study, the follicles used in experiment 1
and 2 were those previously used in our study [15]. The
details of procedures for sample collection of experi-
ment 1 and 2, RNA extraction, microarray analysis,
QPCR analysis, steroid hormone determinations and in
situ hybridization have been described in our previous
report [15]. All procedures for animal experiments were
carried out in accordance with guidelines approved by
the Animal Ethics Committee of the National Institute
of Agrobiological Sciences for the use of animals.
Experiment 1: identification of differentially expressed
SERPIN genes by microarray analysis and QPCR analysis
Sample collection and RNA extraction
Paired ovaries were obtained from four pregnant Japa-
nese Black cows (day 20-27 of pregnancy) in the insti-
tute ranch less than 10 min after slaughtering. These
cows were pregnant and slaughtered for another study.
Follicles that have the largest diameter and second-lar-
gest diameter within the paired ovaries were dissected,
snap-frozen and stored at -80°C until RNA extraction.
We collected three largest and three second-largest folli-
cles from four cows because two cows had both largest
and second-largest follicles collected whereas one cow
had only one largest follicle collected and another cow
had only one second-largest follicle collected. As
described in our previous study [15], we evaluated that
the largest follicles were healthy while the second-largest
follicles were atretic by differences in follicular gene
expression profiles. The mean diameter of largest
(healthy) and second-largest (atretic) follicles were 10.7
± 0.7 mm and 7.8 ± 0.2 mm, respectively. Total RNA
from the follicular wall (i.e., granulosa plus theca
interna) was extracted from each follicle using ISOGEN
(NipponGene, Tokyo, Japan) according to the manufac-
turer’s instructions.
Microarray analysis and quantitative real-time RT-PCR
analysis
We used a custom-made bovine oligonucleotide micro-
array fabricated by Agilent Technologies (Santa Clara,
CA, USA). Sixty-mer nucleotides probes for customized
microarray were synthesized on a glass slide. The anno-
tated bovine oligonucleotide array represented 10263
sequences of which 4466 genes were known bovine
genes including 14 SERPIN genes, 5697 unknown
sequences that were possible candidates for novel bovine
genes, and 100 internal references. We performed one-
color microarray using five follicles (three healthy folli-
cles and two atretic follicles) as previously described
[15]. After data normalization, 3308 genes were left to
use for further analysis. The relative abundance of indi-
vidual genes between follicles was calculated by dividing
the normalized value of the genes between each follicle.
Then, we picked up SERPIN genes that showed fluores-
cence intensities differing by at least a 2.0-fold induction
or a 0.5-fold repression between healthy and atretic fol-
licles and defined these genes as a potentially differential
expression. Compliance with Minimum Information
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assured by depositing all the data in the Gene Expres-
sion Omnibus (GEO) repository [23]. The GEO acces-
sion numbers are as follows. Platform: GPL9136;
Samples: GSM453634, GSM453635, GSM453636,
GSM453637 and GSM453638; Series: GSE18145. We
c o n f i r m e dm R N Ae x p r e s s i o no fs i xp i c k e du pS E R P I N
genes (SERPINA5, SERPINB6, SERPINE1, SERPINE2,
SERPINF2 and SERPING1) using QPCR analysis to vali-
date the results of microarray analysis. All six follicles
were used in QPCR analysis. The procedures for QPCR
were previously described [24]. The primer sequences
for each gene are given in Table 1.
Experiment 2: gene and protein localization of four
SERPINs (SERPINA5, SERPINB6, SERPINF2 and SERPING1)
in E2-active and E2-inactive follicles
Sample collection and follicular fluid steroid hormone
determinations
We obtained eleven large follicles (≥8m mi nd i a m e t e r )
from Japanease Black cows at a local slaughterhouse and
aspirated 200 μl of FF from the each follicle for hor-
mone determinations. The follicles were dissected from
the ovaries and fixed in 10% formalin, embedded in par-
affin wax, and stored at 4°C until in situ hybridization
and immunohistochemistry. The concentrations of E2
and progesterone (P4) in the FF samples were deter-
mined directly in duplicate using a time-resolved fluor-
escent immunoassay as described previously [25,26]. We
classified follicles into two groups based on the relative
levels of E2 and P4 in FF (E2/P4 ≥1: E2-active; E2/P4 <1 :
E2-inactive) [15].
In situ hybridization
Digoxigenin-labeled anti-sense and sense cRNA probes
of each SERPINs were prepared as previously described
[27,28]. For hybridization, follicles were sectioned into
7-μm-thick sections. The procedure for in situ hybridi-
zation using an automated Ventana HX System Discov-
ery with a RiboMapKit and a BlueMapKit (Roche
Diagnostics, Basel, Switzerland) was previously described
[15,27,28].
Immunohistochemistry
Immunohistochemistory was performed using the auto-
mated Ventana HX System Discovery with a DabMapKit
(Roche) described previously by our laboratory [29]. The
7-μm-thick follicular sections were incubated at room
temperature for 4 h with rabbit polyclonal anti-SER-
PINA5 antibody (H00005104, Abnova, Taipei, Taiwan)
diluted 1:10, rabbit polyclonal anti-SERPINB6 antibody
(GTX114637, GeneTex Inc, Irvine, CA, USA) diluted
1:100, rabbit polyclonal anti-SERPINF2 antibody
(H00005345, Abnova) diluted 1:20 or rabbit polyclonal
anti-SERPING1 antibody (GTX105316, GeneTex)
diluted 1:300 in Discovery Ab diluents (Roche). The sec-
tions were then incubated with anti-rabbit IgG-Biotin
conjugate (B7389, Sigma, St. Louis, MO, USA) diluted
1:50 in Discovery Ab diluents (Roche) at room tempera-
ture for 1 h. Immunoreactive signals were detected
using streptavidin-HRP and diaminobenzidine (Dab-
MapKit, Roche). Counter stain was performed by hema-
toxylin and bluing reagent (saturated lithium carbonate
solution). Antibody specificity of these SERPIN antibo-
dies in bovine follicles was confirmed by Western blot
analyses on bovine follicular lysates (GCs and theca
interna).
Statistical analysis
In experiment 1, the expression ratio of each gene to
GAPDH mRNA was calculated to adjust for variations
in the QPCR reaction. QPCR data in experiment 1 was
analyzed by a Mann-Whitney’s U test. Results are pre-
sented as the mean ± SEM. Statistical significance was
considered at P < 0.05.
Table 1 Details of the primers used for quantitative real-time RT-PCR analysis
Gene name GeneBank accession number Primer Sequences Position
SERPINA5 NM_176646 Forward 5’-TGGAAAATGGCCTGAAGGAA-3’ 889-908
Reverse 5’-ATAAAGCTCAAGCCGCCTCTT-3’ 962-942
SERPINB6 NM_174789 Forward 5’-AGCACCCAGATTCTGGTTCTTC-3’ 725-746
Reverse 5’-GTGTTCAAGTCCGTGCTTTCAC-3’ 810-789
SERPINE1 NM_174137 Forward 5’-CAGGCGGACTTCTCCAGTTTT-3’ 1097-1117
Reverse 5’-ACCTCAATCTTCACCTTCTGCAG-3’ 1173-1151
SERPINE2 NM_174669 Forward 5’-CGTAGCACAGACAGATTTGAAGGA-3’ 1068-1091
Reverse 5’- GCAAAATTCGCCTTTGATGG-3’ 1148-1129
SERPINF2 NM_174670 Forward 5’-CCTGGAACAATCAGAACAGCTCT-3’ 579-601
Reverse 5’-TAATGTTCGCCAGGTCTTCCC-3’ 658-638
SERPING1 NM_174821 Forward 5’-GAGATGACCAAGTTCCATCCCA-3’ 1081-1102
Reverse 5’-GTAATCCAGCATGTCCTGACTGC-3’ 1158-1136
GAPDH U85042 Forward 5’- ACCCAGAAGACTGTGGATGG-3’ 444-463
Reverse 5’-CAACAGACACGTTGGGAGTG-3’ 621-602
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Experiment 1
Microarray analysis and quantitative real-time PCR analysis
Among 14 genes coding for the SERPIN superfamily
represented on a bovine oligonucleotide array, 11 SER-
PIN genes were identified after data normalization: SER-
PINA1, SERPINA5, SERPINB1, SERPINB6, SERPINB8,
SERPINE1, SERPINE2, SERPINF1, SERPINF2, SERPING1
and SERPINH1. Of these 11 SERPIN genes, SERPINA5,
SERPINB6, SERPINE2 and SERPINF2 were consistently
up-regulated at least 2.0-fold, while SERPINE1 and
SERPING1 were consistently down-regulated at least
0.5-fold in all healthy follicles compared with all atretic
follicles. We compared the expression levels of these six
SERPINs between healthy and atretic follicles by QPCR.
Figure 1 shows the results of QPCR analysis. Consistent
with the microarray analysis, SERPINA5, SERPINB6,
SERPINE2 and SERPINF2 mRNA expression was greater
in healthy than in atretic follicles (P < 0.05). On
the other hand, SERPINE1 and SERPING1 mRNA
expression was greater in atretic than in healthy follicles
(P < 0.05).
Experiment 2
Among the six SERPINs analyzed by QPCR in experi-
ment 1, we investigated the mRNA and protein localiza-
tion of four (SERPINA5, SERPINB6, SERPINF2 and
SERPING1) in E2-active and E2-inactive follicles. These
SERPINs have not been previously described in bovine
ovarian follicles.
In situ hybridization of four SERPIN genes in E2-active
and E2-inactive follicles
As shown in Figure 2, mRNA expressions of SERPINA5,
SERPINB6 and SERPINF2 were detected in GCs of E2-
active follicles and a weak hybridization signal was also
detected in GCs of E2-inactive follicles (Figure 2A, C, E,
G, I and 2K). SERPING1 mRNA was localized in both
GCs and the TL of E2-inactive follicles and a weak
hybridization signal was also detected in both GCs and
the TL of E2-active follicles (Figure 2M and 2O). No sig-
nificant signals were detected with any sense probes
(Figure 2B, D, F, H, J, L, N and 2P).
Immunohistochemistry of four SERPIN proteins in E2-
active and E2-inactive follicles
SERPINA5, SERPINB6 and SERPINF2 were detected in
GCs of E2-active and E2-inactive follicles (Figure 3A, B,
C, D, E and 3F). SERPING1 protein was localized in
both GCs and the TL of E2-active and E2-inactive folli-
cles (Figure 3G and 3H).
Discussion
This study focused on the mRNA expression of SER-
PINs during bovine follicular development. Microarray
and QPCR analyses revealed that a total of 11 SERPINs
are expressed in both healthy and atretic follicles. Of
these, nine were identified for the first time in bovine
follicle while six were differentially expressed between
healthy and atretic follicles. We also demonstrate that
four of the identified SERPIN genes and proteins
showed stage-specific localization in E2-active and E2-
inactive follicles.
In the present study, the mRNA expression of four
out of six SERPINs differentially expressed between
healthy and atretic follicles was detected for the first
time in bovine follicles. These SERPINs are mainly
involved in regulation of fibrinolytic, coagulation and
protein C pathways. SERPINA5 showed higher mRNA
expression in healthy than in atretic follicles. This SER-
PIN is also called protein C inhibitor and regulates the
coagulation cascade by following three pathways; 1)
inhibition of down-regulation of the coagulation path-
way to inhibit activated protein C (APC), 2) anticoagu-
lant function in the presence of heparin by inhibiting
proteolytic cleavage of fibrinogen by thrombin, 3) pro-
coagulation function in the presence of thrombomodulin
by inhibiting activation of protein C by thrombin [30].
In bovine follicles, GCs express prothorombin (thrombin
precursor) and thrombin receptor (PAR-1) mRNA and
FF contains prothorombin, heparin sulfate and throm-
bin-generating proteins (Factor V, VII and X) [31,32],
suggesting that the coagulation cascade is locally acti-
vated in bovine follicles. Our present result reveals that
mRNA and protein of SERPINA5 was localized only in
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Figure 1 QPCR analysis of SERPINA5, SERPINB6, SERPINE1,
SERPINE2, SERPINF2 and SERPING1 in healthy and atretic
follicles. Total RNA from the follicular wall (i.e., granulosa plus theca
interna) was extracted from three healthy follicles and three atretic
follicles. The expression of mRNA was normalized to the expression
of GAPDH measured in the same RNA preparation. The black and
white bars indicate healthy and atretic follicles, respectively. Data
are shown as the mean ± SEM. Different superscript letters denote
significant differences (P < 0.05).
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of action of protein C and thrombin in bovine follicles.
In addition, APC has direct anti-inflammatory and anti-
apoptotic properties by cleaving PAR-1 [30]. SERPINA5
in healthy follicles may be involved in the regulation of
not only the coagulation cascade but also the anti-
inflammation and anti-apoptotic functions of APC.
SERPING1 (C1 inhibitor) regulates complement path-
way activation and blocks the activity of plasma kallik-
rein and the activated form of factor XII in blood [33].
These two proteins participate in the production of bra-
dykinin, which promotes inflammation by increasing
vascular permeability [34]. The presence of the bradyki-
nin-producing system within follicles has been suggested
in porcine since plasma kallikrein and its physiological
substrate HMW-kininogen coexist in the FF [35]. We
found that SERPING1 mRNA was more highly
expressed in atretic than in healthy follicles and both
mRNA and protein was detected in the GCs and the TL
of E2-inactive follicles. High expression of SERPING1
mRNA in atretic follicles may regulate vascular perme-
ability and suppress inflammation promoted by bradyki-
nin. To support our results, it has been speculated that
bradykinin is involved in the selection and atresia of
ovarian follicles because the porcine study demonstrated
that the concentration of bradykinin in FF of small folli-
cles was higher than in the FF of medium and large fol-
licles [35].
Fibrinolytic cascades, including the PA-plasmin system,
play a crucial role in the degradation and remodeling of
SERPINA5
Anti-sense Sense
E2-active follicle E2-inactive follicle
Anti-sense Sense
SERPINB6
B C D A
SERPINF2
I J K L
E F G H
O P N M
SERPING1
Figure 2 mRNA localization of SERPINA5, SERPINB6, SERPINF2 and SERPING1 in E2-active and E2-inactive follicles. SERPINA5, SERPINB6 and
SERPINF2 mRNA was expressed more in healthy than in atretic follicles, while SERPING1 mRNA was expressed more in atretic than in healthy
follicles in QPCR analysis. (A, C, E, G, I, K, M and O) Digoxigenin (DIG)-labeled anti-sense cRNA probes were used. (B, D, F, H, J, L, N and P) DIG-
labeled sense cRNA probes were used. Sections (7 μm) of bovine follicles were hybridized with each probe. SERPINA5 (A, B, C and D), SERPINB6
(E, F, G and H) and SERPINF2 (I, J, K and L) mRNA were found in the GCs of E2-active follicles and a weak hybridization signal was detected in
GCs of E2-inactive follicles. SERPING1 mRNA (M, N, O and P) was detected in both GCs and the TL of E2-inactive follicles and a weak hybridization
signal was also detected in both GCs and the TL of E2-active follicles. Scale bars = 20 μm.
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development, ovulation and atresia [36]. In the present
study, both SERPINE2 and SERPINF2 mRNA were found
to be more greatly expressed in healthy than in atretic fol-
licles. SERPINE2 is a potent inhibitor of thrombin, plas-
min, both urokinase (uPA) and tissue-type PA (tPA)
[37,38]. mRNA and protein expression of SERPINE2 were
detected in bovine GCs [19]. In accordance with our
results, the FF protein level and mRNA expression of SER-
PINE2 in GCs were higher in non-atretic than in atretic
follicles [21]. SERPINF2 is a known primary physiological
inhibitor of plasmin [17,39]. Our results demonstrated for
the first time that SERPINF2 mRNA is expressed in ovar-
ian follicles and both the mRNA and the protein are
SERPINA5
E2-active follicle E2-inactive follicle
SERPINB6
SERPINF2
SERPING1
Negative
control
A B
C D
I J
E F
H G
Figure 3 Protein localization of SERPINA5, SERPINB6, SERPINF2 and SERPING1 in E2-active and E2-inactive follicles.L o c a l i z a t i o no f
SERPINA5 (A and B), SERPINB6 (C and D), SERPINF2 (E and F) and SERPING1 (G and H) protein was detected by immunohistochemistry. Sections
(7 μm) of bovine E2-active (A, C, E and G) and E2-inactive follicles (B, D, F and H) were incubated with anti-SERPINA5, anti-SERPINB6, anti-
SERPINF2 and anti-SERPING1 polyclonal antibodies. SERPINA5, SERPINB6 and SERPINF2 were detected in the GCs of E2-active and E2-inactive
follicles. SERPING1 was detected in both GCs and the TL of E2-active and E2-inactive follicles. Negative control (I and J) was incubated without
anti-SERPIN antibodies. Scale bars = 20 μm.
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GCs express both SERPINE2 and SERPINF2, suggesting
that GCs may play an important role in the regulation of
the PA-plasmin cascade. Atretic follicles had higher FF
plasmin activity than non-atretic follicles while there was
no difference in mRNA expression levels of uPA [21]. We
previously demonstrated that mRNA expression of uPA
receptor was higher in atretic than in healthy follicles [15].
Therefore, we speculate that the follicular PA-plasmin sys-
tem may mainly be regulated by changes in the balance of
expression of their inhibitors and receptors.
Although SERPINE1 as well as SERPINE2 acts as a
primary inhibitor of both uPA and tPA [40], its mRNA
expression was higher in atretic than in healthy follicles
in contrast to SERPINE2. A previous study showed that
there was no difference in mRNA expression levels of
SERPINE1 between non-atretic and atretic bovine folli-
cles [21]. However, SERPINE1 mRNA expression may
decrease in the process of bovine follicular development
since it was down-regulated in large follicles (10 mm in
diameter) compared with medium-sized follicles (8 mm
in diameter) [14]. SERPINE1 is an acute phase protein
and its production dramatically increases in response to
cytokines such as interleukin-1b (IL-1b) and tumor
necrosis factor a (TNFa) [41,42]. An in vitro study of
cultured rat GCs revealed that both IL-1b and TNFa
suppressed the gonadotropin-induced enhancement of
PAs activity, which was accompanied by an increase in
plasminogen activator inhibitor activity [43,44]. Expres-
sion of TNFa mRNA was greater in bovine GCs of sub-
ordinate follicles compared with DF [7]. Thus, greater
mRNA expression of SERPINE1 in atretic follicles may
be stimulated by enhanced ILs and TNFa production
during follicular atresia.
Healthy follicles also showed greater expression of
SERPINB6 mRNA than atretic follicles. In our present
study, in situ hybridization and immunohistochemistry
revealed that mRNA and protein localization of SER-
PINB6 was restricted only to the GCs of bovine follicles.
It has been demonstrated that Spi/SERPINB6, which is
the mouse ortholog of SERPINB6, and two Spi3/SER-
PINB6 paralogs, NK13/SERPINB6b and Spi3C/SER-
PINB6c, were expressed in a mouse follicular somatic
cells and/or oocytes [45]. A primary target protease of
SERPINB6 is cathepsin G [46], whereas its gene expres-
sion is likely to be restricted to the myeloid lineage [47]
while the expression in ovarian follicular cells is
unknown. SERPINB6 modulates proteolytic activities of
a variety of proteases including plasmin, thrombin, tis-
sue kallikrein and trypsin and b-tryptase [48,49]. mRNA
and protein of tissue kallikrein, thrombin and plasmin
are localized in GCs of bovine antral follicles and are
thought to contribute to regulation of follicular angio-
genesis, coagulation or tissue remodeling [32,50].
SERPINB6 is apparently restricted to the cytoplasm of
cells and cannot be released via the conventional secre-
tory pathway [51]. Thus, we speculate that SERPINB6
may participate in follicular development to inhibit
intracellular proteases in GCs.
Furthermore, we identified for the first time five SER-
PIN genes (SERPINA1, SERPINB1, SERPINB8, SER-
PINF1 and SERPINH1)t h a ta r ee x p r e s s e di nb o v i n e
follicles by microarray analysis. The primary functions
of these SERPINs are inhibition of neutrophil elastase
(SERPINA1 and SERPINB1) [52,53], inhibition of furin
(SERPINB8) [54] and antiangiogenic molecule (SER-
PINF1) [55]. SERPINH1 is known as heat shock protein
47 and is involved in molecular maturation of collagens
to act as a collagen-specific molecular chaperone which
does not have a protease inhibitory function [56]. This
SERPIN may modulate biosynthesis of collagens in folli-
cles regardless of their health status because the mRNA
of collagen types I and IV are detected in GCs and in
the basement membrane of bovine follicles [57]. Our
results imply that numerous SERPINs may constantly
participate in regulation of follicular functions.
Conclusions
We have identified 11 SERPIN genes that are expressed
in bovine follicles by microarray analysis. Of these, six
are differentially expressed between healthy and atretic
follicles. In addition, we have demonstrated for the first
time that mRNA and protein of SERPINA5, SERPINB6
and SERPINF2 showed characteristic localization in the
GCs of follicles, whereas mRNA and protein of SERP-
ING1 was localized in both GCs and TL of E2-active and
E2-inactive follicles. Stage-specific expression of SERPINs
may participate in the growth and atresia of bovine folli-
cles as important mediators of diverse local mechanisms
such as coagulation, protein C and fibrinolytic pathways.
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